Bleomycin sensitivity in patients with familial and sporadic polyposis: a pilot study
Genet. mol. biol
; 22(1): 17-20, Mar. 1999. tab, ilus
Article
in En
| LILACS
| ID: lil-243512
Responsible library:
BR1.1
RESUMO
Human peripheral blood lymphocytes from 10 patients with familial adenomatous polyposis (FAP) showed a significantly higher incidence of chromatid breaks when compared to cells from 10 normal individuals, after exposure to bleomycin (BLM) during the G2 phase. However, no significant increase in bleomycin sensitivity was observed in lymphocytes from 10 patients with sporadic adenomatous polyps (AP) vs. 10 normal individuals (P = 0.67). Individuals that exhibited an average number of chromatid breaks per cell higher than 0.80 were considered sensitive to the drug. No control showed susceptibility to BLM, as compared to 3 out of 20 patients.
Full text:
1
Index:
LILACS
Main subject:
Bleomycin
/
Chromatids
/
Adenomatous Polyposis Coli
/
Antibiotics, Antineoplastic
Type of study:
Diagnostic_studies
Limits:
Adult
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Journal:
Genet. mol. biol
Journal subject:
GENETICA
Year:
1999
Type:
Article